Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Maisch HPLC is a leading German manufacturer specializing in high-performance liquid chromatography (HPLC) columns and stationary phases for the life sciences and chemical industries. Founded in 1995 by Dr. Albin Maisch, the company provides a comprehensive portfolio of products for analytical, UHPLC, and preparative liquid chromatography applications. Its product range includes well-regarded proprietary brands such as ReproSil and GromSil, as well as a suite of brands acquired from Grace/Alltech, including Vydac, Adsorbosphere, and Platinum. The company is particularly recognized for its expertise in proteomics, chiral separations, and patented hardware systems like the DAC and SAC systems for large-scale purification. Based in Ammerbuch, Germany, Dr. Maisch HPLC serves a global clientele of pharmaceutical companies, research institutions, and analytical laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Maisch HPLC.